# Spine BioPharma, Inc. — Form D

Spine BioPharma, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-31. The offering totals $13.0M, of which $1.9M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2023-08-31
- Form: D
- Accession: 0001852647-23-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $13.0M
- Amount sold: $1.9M
- Remaining: $11.1M
- Investors: 1
- Date of first sale: 2023-08-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-491149

## Issuer

- Name: Spine BioPharma, Inc.
- CIK: 0001852647
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 505 PARK AVENUE, 14TH FLOOR, NEW YORK, NY, 10022
- Phone: 212-583-9700

## Officers, directors & promoters (14)

| Name | Role | Location |
| --- | --- | --- |
| Thomas R Bumol, PhD | Director | New York, NY |
| Fran R Magee | Executive Officer | New York, NY |
| Jason J Gallagher | Executive Officer | New York, NY |
| Frank R Cammisa, MD | Director | New York, NY |
| Marc R Viscogliosi | Director | New York, NY |
| Marc R Viscogliosi | Executive Officer | New York, NY |
| LLC J Viscogliosi Brothers, | Executive Officer | New York, NY |
| John J Viscogliosi | Director | New York, NY |
| John J Viscogliosi | Executive Officer | New York, NY |
| Marc R. Viscogliosi | Related Person | New York, NY |
| Fran Magee | Related Person | New York, NY |
| Thomas Bumol, PhD | Related Person | New York, NY |
| Frank Cammisa, MD | Related Person | New York, NY |
| John J. Viscogliosi | Related Person | New York, NY |

## Other filings by this issuer (7)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2026-06-05](https://search.stillhousedata.com/formd/0001852647-26-000002) | D | $8.5M | $385K |
| [2024-12-18](https://search.stillhousedata.com/formd/0001852647-24-000001) | D | $23.5M | $13.5M |
| [2023-10-11](https://search.stillhousedata.com/formd/0001852647-23-000004) | D | $15.0M | $2.4M |
| [2023-02-08](https://search.stillhousedata.com/formd/0001852647-23-000001) | D | $13.0M | $13.0M |
| [2022-03-24](https://search.stillhousedata.com/formd/0001852647-22-000003) | D | $30.4M | $13.0M |
| [2021-04-20](https://search.stillhousedata.com/formd/0001192482-21-000343) | D | $3.0M | $3.0M |
| [2021-03-22](https://search.stillhousedata.com/formd/0001192482-21-000264) | D | $5.0M | $5.0M |

## More

- [CIK 1852647 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1852647&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001852647-23-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.